Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
2.020
+0.070 (3.59%)
At close: Jul 2, 2026, 4:00 PM EDT
2.000
-0.020 (-0.99%)
After-hours: Jul 2, 2026, 6:37 PM EDT
Tvardi Therapeutics Employees
Tvardi Therapeutics had 12 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,286,583
Market Cap
18.95M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | 0 | - |
| Dec 31, 2024 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Palatin Technologies | 29 |
| SeaStar Medical Holding | 17 |
| Atossa Therapeutics | 16 |
| Lipocine | 14 |
| NewcelX | 12 |
| AEON Biopharma | 8 |
| Neuphoria Therapeutics | 8 |
TVRD News
- 27 days ago - Tvardi Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 6 weeks ago - Tvardi Therapeutics to Participate in Upcoming Investor Events - GlobeNewsWire
- 2 months ago - Tvardi Therapeutics reports Q1 EPS (73c), consensus (72c) - TheFly
- 2 months ago - Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Tvardi Therapeutics files $200M mixed securities shelf - TheFly
- 2 months ago - Tvardi Therapeutics downgraded to Underweight from Equal Weight at Barclays - TheFly
- 3 months ago - Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium - GlobeNewsWire
- 3 months ago - Tvardi Therapeutics price target lowered to $3 from $4 at Piper Sandler - TheFly